Early market access of cancer drugs in the EU.

MLA

Martinalbo, J., et al. “Early Market Access of Cancer Drugs in the EU.” Annals of Oncology, vol. 27, no. 1, Jan. 2016, pp. 96–105. EBSCOhost, https://doi.org/10.1093/annonc/mdv506.

APA

Martinalbo, J., Bowen, D., Camarero, J., Chapelin, M., Démolis, P., Foggi, P., Jonsson, B., Llinares, J., Moreau, A., O’Connor, D., Oliveira, J., Vamvakas, S., & Pignatti, F. (2016). Early market access of cancer drugs in the EU. Annals of Oncology, 27(1), 96–105. https://doi.org/10.1093/annonc/mdv506

Chicago

Martinalbo, J., D. Bowen, J. Camarero, M. Chapelin, P. Démolis, P. Foggi, B. Jonsson, et al. 2016. “Early Market Access of Cancer Drugs in the EU.” Annals of Oncology 27 (1): 96–105. doi:10.1093/annonc/mdv506.